首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1414109

2024 年克隆與誘變全球市場報告

Cloning And Mutagenesis Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，克隆/誘變市場迅速擴大。將從2023年的25.3億美元擴大到2024年的30.5億美元，複合年成長率為20.6%。過去研究期間出現的擴張是由於基因研究的進步、藥物研究需求的增加、農業基因工程的擴散、生物醫學研究的應用以及分子生物學的開創性應用。

2023年，北美是克隆和誘變市場最大的地區。在全球克隆和誘變市場報告中，亞太地區預計將成為預測期內成長最快的地區。克隆和誘變市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

全球克隆和誘變市場，按產品細分，實際和預測，2018-2023、2023-2028、2033
克隆套件
誘變試劑套件
其他
全球克隆和誘變市場，按技術細分，實際和預測，2018-2023、2023-2028、2033
平末端克隆
TOPO PCR 克隆
無縫克隆
定點特異性
其他
全球克隆和誘變市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
學術研究所
生技公司
其他

第 7 章區域與國家分析

全球克隆與誘變市場，按地區、實際和預測，2018-2023、2023-2028、2033
全球克隆和誘變市場，按國家、業績和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

克隆與誘變市場競爭形勢
克隆和誘變市場公司概況
- Thermo Fisher Scientific
- Takara Bio Inc.
- Agilent Technologies Inc.
- Jena Bioscience GmbH
- Transgen Biotech Co

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章重大併購

第34章未來前景與可能性分析

第35章附錄

簡介目錄

Product Code: r11619

“Cloning And Mutagenesis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cloning and mutagenesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cloning and mutagenesis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cloning and mutagenesis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Cloning Kits; Mutagenesis Kits; Other Product
2) By Technique: Blunt End Cloning; Topo PCR Cloning; Seamless Cloning; Site-Directed Mutagenesis; Other Techniques
3) By End User: Academic and Research Institutes; Biotechnology Companies; Other End User
Companies Mentioned: Thermo Fisher Scientific; Takara Bio Inc.; Agilent Technologies Inc.; Jena Bioscience GmbH; Transgen Biotech Co
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.

The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.

The cloning and mutagenesis software market research report is one of a series of new reports from The Business Research Company that provides cloning and mutagenesis software market statistics, including cloning and mutagenesis software industry global market size, regional shares, competitors with a cloning and mutagenesis software market share, detailed cloning and mutagenesis software market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis software industry. This cloning and mutagenesis software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cloning and mutagenesis market size has grown exponentially in recent years. It will grow from $2.53 billion in 2023 to $3.05 billion in 2024 at a compound annual growth rate (CAGR) of 20.6%. The expansion observed in the historical period can be ascribed to progress in genetic research, heightened demand for pharmaceutical research, the surge of genetic engineering in agriculture, applications in biomedical research, and pioneering applications in molecular biology.

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $6.07 billion in 2028 at a compound annual growth rate (CAGR) of 18.8%. The anticipated growth in the forecast period can be linked to the widening applications in gene therapy, increasing demand for personalized medicine, advancements in functional genomics, innovations in synthetic biology, and applications in agricultural biotechnology. Major trends expected in the forecast period include targeted gene editing in therapeutics, improved precision and specificity, customizable molecular tools, expanded applications in agriculture, and considerations related to ethics and regulations.

The cloning and mutagenesis market is expected to experience growth driven by the rising demand for genetically modified products. Genetically modified products involve organisms, materials, or substances that undergo deliberate genetic engineering to introduce new traits or characteristics. Cloning, a scientific process for producing exact genetic copies, is utilized in various applications, including creating insect and plant-resistant species and facilitating gene therapy in medical sciences. An annual report from Bayar AG, a Germany-based biotechnology and pharmaceutical company, revealed significant growth in the sales of genetically modified products, with the crop sciences segment reaching $27,794.38 million in 2022, up from $22,314.79 million in 2021. This increased demand for genetically modified products is a key driver of the cloning and mutagenesis market. The data is based on information provided in the annual report published by Bayar AG in February 2023.

The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. In April 2022, the Personalized Medicine Coalition reported that the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Among the therapeutic NMEs, approximately 34% (12 of them) were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.

Major players in the cloning and mutagenesis market are leveraging advanced technologies, such as bacteriophage genome modifying technologies, to enhance their competitive position. Bacteriophage genome modifying technologies involve intentional alterations to the genetic material of bacteriophages, viruses that infect bacteria, for applications in research, therapy, or industry. An example is iNtRON Biotechnology, a South Korea-based biotech company, which introduced its 2nd generation Robot Bacteriophage technology in October 2022. This technology utilizes random transposon mutagenesis to modify the bacteriophage genome, enabling the identification and removal of non-essential genes. iNtRON aims to design and produce bacteriophages with specific characteristics, facilitating the development of immunotherapeutic agents and antiviral solutions.

Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.

In April 2021, Charles River Laboratories International Inc., a US-based pharmaceutical company specializing in preclinical and clinical services, completed the acquisition of Cognate BioServices for $875 million. This strategic move is designed to position Charles River as a comprehensive solution provider, covering both fundamental research and Current Good Manufacturing Practice (CGMP) production. Cognate BioServices, the acquired entity, is a US-based biotechnology company with a focus on the development of cell and cell-mediated gene therapies. This acquisition reflects Charles River's commitment to expanding its capabilities in the field of biotechnology and reinforcing its position in the preclinical and clinical services market.

Major companies operating in the cloning and mutagenesis market report are Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd., GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.

North America was the largest region in the cloning and mutagenesis market in 2023. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

1. Executive Summary

2. Cloning And Mutagenesis Market Characteristics

3. Cloning And Mutagenesis Market Trends And Strategies

4. Cloning And Mutagenesis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Cloning And Mutagenesis Market Size and Growth

5.1. Global Cloning And Mutagenesis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cloning And Mutagenesis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cloning And Mutagenesis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cloning And Mutagenesis Market Segmentation

6.1. Global Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cloning Kits
Mutagenesis Kits
Other Product
6.2. Global Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Blunt End Cloning
Topo PCR Cloning
Seamless Cloning
Site-Directed Mutagenesis
Other Techniques
6.3. Global Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Academic and Research Institutes
Biotechnology Companies
Other End User

7. Cloning And Mutagenesis Market Regional And Country Analysis

7.1. Global Cloning And Mutagenesis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cloning And Mutagenesis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cloning And Mutagenesis Market

8.1. Asia-Pacific Cloning And Mutagenesis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cloning And Mutagenesis Market

9.1. China Cloning And Mutagenesis Market Overview
9.2. China Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cloning And Mutagenesis Market

10.1. India Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cloning And Mutagenesis Market

11.1. Japan Cloning And Mutagenesis Market Overview
11.2. Japan Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cloning And Mutagenesis Market

12.1. Australia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cloning And Mutagenesis Market

13.1. Indonesia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cloning And Mutagenesis Market

14.1. South Korea Cloning And Mutagenesis Market Overview
14.2. South Korea Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cloning And Mutagenesis Market

15.1. Western Europe Cloning And Mutagenesis Market Overview
15.2. Western Europe Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cloning And Mutagenesis Market

16.1. UK Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cloning And Mutagenesis Market

17.1. Germany Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cloning And Mutagenesis Market

18.1. France Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cloning And Mutagenesis Market

19.1. Italy Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cloning And Mutagenesis Market

20.1. Spain Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cloning And Mutagenesis Market

21.1. Eastern Europe Cloning And Mutagenesis Market Overview
21.2. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cloning And Mutagenesis Market

22.1. Russia Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cloning And Mutagenesis Market

23.1. North America Cloning And Mutagenesis Market Overview
23.2. North America Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cloning And Mutagenesis Market

24.1. USA Cloning And Mutagenesis Market Overview
24.2. USA Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cloning And Mutagenesis Market

25.1. Canada Cloning And Mutagenesis Market Overview
25.2. Canada Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cloning And Mutagenesis Market

26.1. South America Cloning And Mutagenesis Market Overview
26.2. South America Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cloning And Mutagenesis Market

27.1. Brazil Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cloning And Mutagenesis Market

28.1. Middle East Cloning And Mutagenesis Market Overview
28.2. Middle East Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cloning And Mutagenesis Market

29.1. Africa Cloning And Mutagenesis Market Overview
29.2. Africa Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cloning And Mutagenesis Market Competitive Landscape And Company Profiles

30.1. Cloning And Mutagenesis Market Competitive Landscape
30.2. Cloning And Mutagenesis Market Company Profiles
- 30.2.1. Thermo Fisher Scientific
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Takara Bio Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Agilent Technologies Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Jena Bioscience GmbH
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Transgen Biotech Co
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Cloning And Mutagenesis Market Competitive Benchmarking

32. Global Cloning And Mutagenesis Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cloning And Mutagenesis Market

34. Cloning And Mutagenesis Market Future Outlook and Potential Analysis

34.1 Cloning And Mutagenesis Market In 2028 - Countries Offering Most New Opportunities
34.2 Cloning And Mutagenesis Market In 2028 - Segments Offering Most New Opportunities
34.3 Cloning And Mutagenesis Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies